Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1353 (LINC01353)
- Target
- LINC01353
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 1353 (LINC01353) is a human long intergenic non-coding RNA identified in genomic databases, with accessions including 100506775 (NCBI Gene) and ENSG00000231507 (Ensembl)[1]. LINC01353 belongs to the class of lincRNAs, which are defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes[5][7]. While long intergenic non-coding RNAs as a group can serve diverse regulatory functions—such as controlling gene expression, structuring chromatin, and influencing transcription—there is currently no direct, published experimental evidence for specific biological roles, disease associations, or drug interactions for LINC01353 itself in the available literature and database records[1][5][7]. Therefore, LINC01353 is not considered a validated therapeutic target based on present information.
- Other names
- LINC01353
02
Biological functions
Gene regulation (potential, inferred from the general function of lincRNAs)Chromatin and genome architecture remodeling (general lincRNA property)Transcription regulation, possibly including enhancer-associated activity (general lincRNA property)
03
Disease associations
Unknown/Other (no specific disease associations identified for LINC01353 in the available sources)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1353 (LINC01353).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1353 (LINC01353).